We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets. An orphan disease is...
Read More
Companies that thrive on sustaining products over a long period are always at risk of classic disruptive innovation—losing business to a smaller company with fewer resources that jumps in, improves...
Read More
The idea that a company’s success depends on how much it can leverage the skills of its employees’ bright minds is rapidly becoming an outdated concept. Companies that are equipped...
Read More
Redundancies in any professional field mean dollars lost. But in healthcare, inefficiency can cost lives. That’s a reality that Gunjan Bhardwaj came to understand when his friend and mentor was diagnosed...
Read More
In this special guest feature, Gunjan Bhardwaj, Founder and CEO of Innoplexus, discusses how data silos in pharma prevent the latest advancements in machine learning and data analytics from operating...
Read More
Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries. They are often thrilled about laboratory experiments and preclinical studies, regardless of...
Read More
The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s, such as Salvarsan and insulin, to the blockbuster drugs birthed...
Read More
“If I have seen further than others, it is by standing upon the shoulders of giants.” – Isaac Newton There is nothing new under the sun. Innovation is an iterative process—all...
Read More
Ask the average person about the blockchain, and you’d be lucky if one in ten could tell you – even in vague terms – how the technology works, or even...
Read More
[video width="960" height="540" mp4="https://www.innoplexus.com/wp-content/uploads/2018/07/gunjan-bhardwaj-phd-ceo-founder-innoplexus.mp4"][/video] Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global...
Read More
